Use of Tox21 Screening Data to Evaluate the COVID-19 Drug Candidates for Their Potential Toxic Effects and Related Pathways.

Front Pharmacol · 2022 · PMC9333127 · PMID 35910344

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an observed trendno p-value reported

In a randomized clinical trial, ivermectin has not shown any significant improvement in treating mild COVID-19 patients ( Lopez-Medina et al., 2021 ), but there was an observed trend in reducing the hospital stay for ivermectin-treated group ( Abd-Elsalam et al., 2021 ).

also in 504 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.